Elixxer Ltd
Elixxer Ltd. does not have significant operations. The company invests in the cultivation and production of cannabis products. Elixxer Ltd. is based in Montreal, Canada.
Market Cap & Net Worth: Elixxer Ltd (ELIXF)
Elixxer Ltd (PINK:ELIXF) has a market capitalization of $69.17K ($69.17K) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #44848 globally and #14166 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Elixxer Ltd's stock price $0.01 by its total outstanding shares 11338887 (11.34 Million).
Elixxer Ltd Market Cap History: 2017 to 2025
Elixxer Ltd's market capitalization history from 2017 to 2025. Data shows change from $383.71 Million to $69.17K (-69.62% CAGR).
Elixxer Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Elixxer Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
2.28x
Elixxer Ltd's market cap is 2.28 times its annual revenue
1.02x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $81.53 Million | $101.93K | -$9.77 Million | 799.79x | N/A |
| 2019 | $40.82 Million | $71.17K | -$8.01 Million | 573.56x | N/A |
| 2020 | $10.08 Million | $9.38K | -$5.64 Million | 1074.53x | N/A |
| 2021 | $12.50 Million | $31.44K | -$2.15 Million | 397.45x | N/A |
| 2022 | $9.07 Million | $66.95K | -$14.17 Million | 135.49x | N/A |
| 2023 | $187.09K | $82.13K | -$5.11 Million | 2.28x | N/A |
Competitor Companies of ELIXF by Market Capitalization
Companies near Elixxer Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to Elixxer Ltd by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Elixxer Ltd Historical Marketcap From 2017 to 2025
Between 2017 and today, Elixxer Ltd's market cap moved from $383.71 Million to $ 69.17K, with a yearly change of -69.62%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $69.17K | 0.00% |
| 2024 | $69.17K | -63.03% |
| 2023 | $187.09K | -97.94% |
| 2022 | $9.07 Million | -27.40% |
| 2021 | $12.50 Million | +23.96% |
| 2020 | $10.08 Million | -75.31% |
| 2019 | $40.82 Million | -49.93% |
| 2018 | $81.53 Million | -78.75% |
| 2017 | $383.71 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Elixxer Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $69.17K USD |
| MoneyControl | $69.17K USD |
| MarketWatch | $69.17K USD |
| marketcap.company | $69.17K USD |
| Reuters | $69.17K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.